Infertility and Miscarriage

Pipeline Programs

Companies

Clinical Trials

2 recruiting

Approved Products

Pipeline by Development Stage

Preclinical

Phase 1

Phase 1/2

Phase 2

Phase 2/3

Phase 3

On Market

Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Pre

P1/2

P2/3

Mkt

UNION therapeuticsDenmark - Hellerup

1 program

Transcervical resection of septumN/A2 trials

Active Trials

NCT07039097Recruiting418Est. Jun 2030

NCT07611656Recruiting236Est. Jun 2030

Trial Timeline

Clinical trial activity over time

2025

2026

2027

2028

2029

2030

UNION therapeuticsTranscervical resection of septum

Clinical Trials (2)

Total enrollment: 654 patients across 2 trials

NCT07039097 UNION therapeuticsTranscervical resection of septum

A Multicenter, Prospective, Randomized, Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resection on the Natural Pregnancy Outcomes in Patients With Non-recurrent Spontaneous Abortion

Start: Jun 2025Est. completion: Jun 2030418 patients

N/ARecruiting

NCT07611656 UNION therapeuticsTranscervical resection of septum

A Multicenter, Prospective, Randomized Controlled Clinical Study on the Effect of Hysteroscopic Uterine Septum Resection on IVF-ET Outcomes in Infertile Patients With Non-recurrent Miscarriage

Start: Jun 2025Est. completion: Jun 2030236 patients

N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies

Phase 1— Safety & dosing

Phase 2— Efficacy testing

Phase 3— Large-scale trials

On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 654 patients

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.